Chitinase-3 like-protein-1, a prognostic biomarker in patients with hepatocellular carcinoma and concomitant myosteatosis
Elevated CHI3L1 was negatively correlated with SMRA, and predicted poorer prognosis in Chinese population after LT for HCC, especially in those patients with concomitant myosteatosis. Monitoring serum CHI3L1 can predict prognosis and effectively guide individual nutrition intervention.
Authors
- Chenghao Cao (ORCID: https://orcid.org/0009-0000-3344-7552)
- Huigang Li (ORCID: https://orcid.org/0000-0002-5575-8068)
- Zuyuan Lin
- Xudong Yang (ORCID: https://orcid.org/0000-0003-4669-4821)
- Hao Chen (ORCID: https://orcid.org/0000-0002-9448-1436)
- Jinyan Chen (ORCID: https://orcid.org/0000-0003-4103-7056)
- Zhihang Hu
- Xuyong Wei (ORCID: https://orcid.org/0000-0001-8755-5268)
- Xiao Xu (ORCID: https://orcid.org/0000-0001-9783-6776)
- Li Zhuang (ORCID: https://orcid.org/0000-0001-9056-7681)
- Shusen Zheng (ORCID: https://orcid.org/0000-0003-1459-8261)
- Di Lu (ORCID: https://orcid.org/0000-0003-1040-7763)
- Wei Shen (ORCID: https://orcid.org/0009-0003-9347-3842)
- Chiyu He
Institutions
- Hangzhou Normal University (CN)
- Zhejiang Shuren University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Hangzhou Red Cross Hospital (CN)
- Zhejiang University-University of Edinburgh Institute (CN)
- Ministry of Public Health (MG)
- Hangzhou Medical College (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1186/s12885-024-12808-3
- Citations
- 2
- Primary Topic
- Studies on Chitinases and Chitosanases
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- National Natural Science Foundation of China
- Major Research Plan
- National Key Research and Development Program of China